SpaceX’s latest quarterly print presents a study in contrasts: operating performance that outpaced expectations sitting alongside a stock decline driven by structural changes in the company’s share supply. The company posted $7.8 billion in Q2 revenue, a 92% increase versus the prior year and roughly $1 billion ahead of consensus, while adjusted EBITDA reached $3.5 billion, a 191% jump that produced a 45% EBITDA margin.
The market response was negative on the day of the release, with the share price trading near $115.11, down about 8.15% intraday and far below the 52-week high of $225.64. That reaction has less to do with the quarter’s core economics and more to do with an anticipated surge in available stock.
Financial scorecard
- Price and range: Trading around $115.11, down 8.15% on the session; 52-week range $104.83 to $225.64.
- Q2 revenue: $7.8 billion, +92% year-over-year, roughly $1 billion above expectations.
- Q2 adjusted EBITDA: $3.5 billion, +191% year-over-year, yielding a 45% EBITDA margin.
- Gross margin: Approximately 55% as disclosed, and EBITDA margin at 45% — unusually high for a hardware-centric aerospace company.
Those margin figures are notable in an industry where heavy manufacturing and launch costs typically compress profitability. The combination of strong top-line acceleration and elevated margins underpins the argument that current weakness in the equity is not primarily a demand or operational problem.
The supply-side narrative
The clearest explanation for near-term selling is mechanical: a dramatic widening of the tradable share pool. Multiple lockup expiries and scheduled unlocks will meaningfully expand the float over the next year. Specific elements include:
- Immediate lockup expiry that allows up to 912 million shares to trade, a number that could roughly double the current float.
- A mid-2027 unlock that will free an additional 12.9 billion shares over the following 12 months.
- An expected increase in tradable shares from less than 5% of total shares to roughly 50% by June 2027.
- Concurrent FY2027 capital expenditure plans of approximately $65 billion, which is about $17 billion higher than earlier estimates.
Faced with that combination of an enlarged float and elevated near-term capex, some analysts have reworked valuation multiples even while upgrading business forecasts. One firm reduced its target multiple from 20x to 12x on 2031 EV/EBITDA - a level the firm previously associated with the lowest multiples seen for certain peers - while simultaneously raising its earnings estimates, a statement that the business outlook has improved but that the near-term share structure is unappealing.
Where the bullish case centers
The investment thesis that remains bullish is narrowly focused: if the selling pressure is indeed caused by a front-loaded lockup and temporary float imbalance, then the technical headwind should abate once institutions are able to scale positions in a larger, more liquid market. Several points reinforce that perspective:
- Company guidance implies a steep revenue path, with management projecting a $100 billion annualized run-rate by year-end 2026.
- Starlink developments: V3 satellites are said to deliver ten times the broadband capacity of V2, and the 14th Starship test - targeting late August 2026 - is expected to carry the first tranche of these satellites.
- Starlink’s commercial uptake includes live service on 41 airlines and ongoing share gains versus terrestrial telecom providers.
- Emerging revenue categories: an initiative called Starmind orbital compute could translate orbital capacity into a leasable product. At the stated scale, 200 Starship launches would equal 1 GW of orbital compute capacity, which management estimates could be leasable for $30 billion to $50 billion per year.
One investment bank maintained an Outperform rating after the results and characterized Starlink as a disruptive telecom opportunity with few serious orbital competitors, a framing that supports a longer-term constructive view if technical selling pressures subside.
Execution and headline risks
That bullish view is tempered by execution-sensitive variables. A comment from company leadership about canceling an AMD processor arrangement led to an immediate market move in AMD shares, down more than 8%, and raised questions about the component sourcing strategy for SpaceX’s own AI ambitions. The implication is that reliance on a concentrated supplier set - for example, a heavy tilt toward a particular class of processors - could introduce execution risk.
Additionally, management has set an aggressive cadence goal for Starship flights - daily launches within a year - which, if achieved, would drive substantial cost improvements and potentially validate the high capex as productive investment rather than an unsustainable outlay. But the converse is also true: the large FY2027 capex program will absorb significant free cash flow, and contractual AI cloud commitments can be cancellable, exposing a portion of projected revenue to churn.
Bottom line
SpaceX’s quarter reads like an operating success: rapid revenue growth, exceptional gross and EBITDA margins, and a set of emerging businesses that could materially expand addressable markets. The market’s negative reaction, however, appears to be rooted more in the imminent enlargement of the tradable share base and a heavy near-term capex schedule than in a deterioration of unit economics. If the supply-driven pressure is temporary, the technical backdrop could reverse when institutional buyers are able to participate in a normalized float. Conversely, the magnitude of capex and the extended schedule of share unlocks leave room for sustained volatility.